Ilya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the different classes of drugs in diabetes today and discussed in greater detail the mechanism of action for the newer drugs. We also discuss how to prescribe the newer SGLT2 inhibitors and review different mechanisms for adverse effects and cardiovascular benefit. This is episode one of four in our Diabeto-cardiology series. Let's get to know the drugs first.
Listen, Like, Subscribe and don't forget to give us a Rating!!
Diabetes management is evolving and we discuss the role of cardiologists in improving cardio-metabolic care. Dr Muthiah Vaduganathan from Brigham and Women's Hospital & Harvard Medical School shares his expertise on the evidence for newer drugs and how cardiologists can get engaged in diabetes management. This is episode three of four in our Diabeto-Cardiology series. Listen, Like, Subscribe, Tweet and don't forget to give us a Rating!!
Ilya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the different classes of drugs in diabetes today and discussed in greater detail the mechanism of action for the newer drugs. We also discuss how to prescribe the newer SGLT2 inhibitors and review different mechanisms for adverse effects and cardiovascular benefit. This is episode one of four in our Diabeto-cardiology series. Let's get to know the drugs first.
Listen, Like, Subscribe and don't forget to give us a Rating!!